Skip to main navigation Skip to search Skip to main content

Presence of Intracardiac Thrombus at the Time of Left Ventricular Assist Device Implantation Is Associated With an Increased Risk of Stroke and Death

  • Claudio A. Bravo
  • , Justin A. Fried
  • , Joshua Z. Willey
  • , Azka Javaid
  • , Giulio M. Mondellini
  • , Lorenzo Braghieri
  • , Heidi Lumish
  • , Veli K. Topkara
  • , Yuji Kaku
  • , Lucas Witer
  • , Hiroo Takayama
  • , Koji Takeda
  • , Gabriel Sayer
  • , Nir Uriel
  • , Ryan T. Demmer
  • , Yoshifumi Naka
  • , Melana Yuzefpolskaya
  • , Paolo C. Colombo

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Heart failure predisposes to intracardiac thrombus (ICT) formation. There are limited data on the prevalence and impact of preexisting ICT on postoperative outcomes in left ventricular assist device patients. We examined the risk for stroke and death in this patient population. Methods and Results: We retrospectively studied patients who were implanted with HeartMate (HM) II or HM3 between February 2009 and March 2019. Preoperative transthoracic echocardiograms, intraoperative transesophageal echocardiograms and operative reports were reviewed to identify ICT. There were 525 patients with a left ventricular assist device (median age 60.6 years, 81.8% male, 372 HMII and 151 HM3) included in this analysis. An ICT was identified in 44 patients (8.4%). During the follow-up, 43 patients experienced a stroke and 55 died. After multivariable adjustment, presence of ICT increased the risk for the composite of stroke or death at 6-month (hazard ratio [HR] 1.82, 95% confidence interval [CI] 1.00–3.33, P = .049). Patients with ICT were also at higher risk for stroke (HR 2.45, 95% CI 1.14–5.28, P = .021) and death (HR 2.36, 95% CI 1.17–4.79 P = .016) at 6 months of follow-up. Conclusions: The presence of ICT is an independent predictor of stroke and death at 6 months after left ventricular assist device implantation. Additional studies are needed to help risk stratify and optimize the perioperative management of this patient population.

Original languageEnglish (US)
Pages (from-to)1367-1373
Number of pages7
JournalJournal of cardiac failure
Volume27
Issue number12
Early online dateJun 20 2021
DOIs
StatePublished - Dec 2021

Bibliographical note

Funding Information:
Dr Colombo is the recipient of a research grant from Abbott; he also serves as a consultant for Abbott. Dr Naka serves as a consultant for Abbott, CryoLife, and Zimmer-Biomet, and as a speaker for Nipro Co. Dr Sayer serves as a consultant for Abbott. Dr Uriel serves on advisory boards for Leviticus and Livemetric/Cormetric; he also serves as a consultant for Abbott and Medtronic. The other authors report no conflicts.

Funding Information:
Supported by funds from the Lisa and Mark Schwartz Program to Reverse Heart Failure at New York-Presbyterian Hospital/Columbia University .

Publisher Copyright:
© 2021 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Heart failure
  • assist device
  • intracardiac thrombus
  • left ventricular

Fingerprint

Dive into the research topics of 'Presence of Intracardiac Thrombus at the Time of Left Ventricular Assist Device Implantation Is Associated With an Increased Risk of Stroke and Death'. Together they form a unique fingerprint.

Cite this